BBlogFlow

Manitoba will hire up to 90 family doctors by 2029 with $6M in federal funding: health minister - CBC

·2d ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

ManitobaThe federal government is putting up about $6 million to hire as many as 90 internationally trained doctors by 2029 to work in Manitoba, primarily in rural and remote communities, provincial and federal health ministers said Wednesday. Will expand program for internationally trained docs, with focus on rural, remote areas, says Uzoma AsagwaraCBC News · Posted: Oct 14, 2026 3:25 PM EDT | Last Updated: October 14Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Manitoba Health Minister Uzoma Asagwara, shown in a file photo, said Wednesday the province's goal is to use federal funding to boost the number of doctors in rural and remote areas. (Trevor Brine/CBC)The federal government is putting up about $6 million to hire as many as 90 internationally trained doctors by 2029 to work in Manitoba, primarily in rural and remote communities, provincial and federal health ministers said Wednesday.

This article is an excerpt. To read the full content, visit the original source. CBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·